Resmed has received clearance from the U.S. Food and Drug Administration (FDA) for an artificial intelligence (AI)-enabled ...
Resmed (NYSE: RMD) announced today that it received FDA clearance for its Smart Comfort personalized therapy comfort settings ...
Sleep apnea has become a global health concern, affecting millions of people and leading to fatigue, cardiovascular disease, and other chronic health issues. To address this widespread problem, ResMed ...
Technology uses real-world sleep data and machine learning to help people with sleep apnea start and stay on therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback